In The Press November 09, 2022

U.S. Legislative Update: Takeaways for European Pharma (European Pharmaceutical Review)

IP Litigation partner Keith Zullow and senior associate Jenny Zhang examine upcoming U.S. pharmaceutical regulation and how, if passed, it could impact European pharma/biopharma companies looking to access the U.S. market in European Pharmaceutical Review.